Follow-up study of olfactory deficits, cognitive functions, and volume loss of medial temporal lobe structures in patients with mild cognitive impairment

Current Alzheimer Research

Volumn 8, Issue 6, 2011, Pages 689-698

  Lojkowska, W ^a   Sawicka, B ^a   Gugala, M ^a   Sienkiewicz Jarosz, H ^a   Bochynska, A ^a   Scinska, A ^b   Korkosz, A ^b   Lojek, E ^c   Ryglewicz, D ^a  

^a 1st Department of Neurology   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

Amygdala; Cognitive functions; Hippocampus; Mild cognitive impairment; Mri; Odor; Olfaction; Parahippocampal gyrus

Indexed keywords

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; MALE; MENTAL DETERIORATION; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY SYSTEM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMELLING; SUBICULUM; TEMPORAL LOBE;

AGED; COGNITION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; OLFACTION DISORDERS; ORGAN SIZE; TEMPORAL LOBE;

EID: 80051711930     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720511796717212     Document Type: Article

References (52)

1. Petersen RC, Doody R, Kurz A, Mohs RC, Rabins PV, Richie K, et al. Current concepts in mild cognitive impairment. Arch Neurol 58: 1985-1992 (2001).
2. Petersen RC. Early diagnosis of Alzheimer's Disease: Is MCI too late? Current Alzheimer Res 6: 324-330 (2009).
3. Smith GE, Ivnik RJ, Petersen RC, Malec JF, Kokmen E, Tangalos E. Age-associated memory impairment diagnoses: problems of reliability and concerns for terminology. Psychol Aging 6: 551-558 (1991).
4. Devanand DP, Michals-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, et al. Olfactory deficits with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 157: 1399-1405 (2000).
5. Doty RL, Perl DP, Steele JC, Chen KM, Pierce JD Jr, Reyes P, et al. Olfactory deficits in three neurodegenerative diseases. Geriatrics 46 Suppl: 47-51 (1991).
6. Kesslak JP, Cotman CW, Chui HC, Van den Noort, Fang H, Pfeffer R, et al. Olfactory tests as possible probes for detecting and monitoring Alzheimer's disease. Neurobiol Aging 9: 399-403 (1988).
7. Morgan CD, Nordis S, Murphy C. Odor identification is an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. J Clin Exp Neuropsychol 17: 793-803 (1995).
8. Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh- Bohmer K. Taste, smell and neuropsychological performance in individual at familial risk to Alzheimer's disease. Neurobiol Aging 23: 397-404 (2002).
9. Eibenstein A, Fioretti AB, Simaskou MN, Sucapane P, Mearrelli, Mina C, et al. Olfactory screening test in mild cognitive impairment. Neurol Sci 26: 156-160 (2005).
10. Westervelt HJ, Ruffo JS, Temont G. Assessing olfaction in the neuropsychological exam: The relationship between odor identification and cognition in older adults. Arch Clin Neuropsychol 20: 761-79 (2005).
11. Wilson RS, Schneider JA, Arnold SE, Tang Y, Boyle PA, Bennett DA. Olfactory identification and incidence of mid cognitive impairment in older age. Arch Gen Psychiatry 64: 802-808 (2007).
12. Westervelt HJ, Bruce JM, Coon WG, Tremont GJ. Odor identification in mild cognitive impairment subtypes. J Clin Exp Neuropsychol 30: 151-156 (2008).
13. Djordjevic J, Jones-Gotman M, De Sousa K, Chertkow H. Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 29: 693-706 (2008).
14. Schubert CR, Carmischel LL, Murphy C, Klein BE, Klein R, Cruickshanks KJ. Olfaction ant the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc 56: 1517-1521 (2008).
15. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's Disease. Biol Psychiatry 64: 871-879 (2008).
16. Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, et al. Olfactory identification deficits and MCI in a multi-ethnic eldery community sample. Neurobiol Aging 31(9): 1593-1600 (2010). Epub 2008 Oct. 28.
17. Murphy C, Jernigan TL, Fennema-Notestine Ch. Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identifications. J Intern Neuropsychol Soc 9: 459-471 (2003).
18. Wolf H, Grunwald M, Kruggel F, Riedel-Heller SG, Angerhofer S, Hojjatoleslami A, et al. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging 22: 177-186 (2001).
19. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weingard MS, Knopman DS, et al. Comparison of different MRI brain atrophy rate measures with clinical diseases progression in AD. Neurology 62: 591-600 (2004).
20. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment. Prediction of Alzheimer's disease. Neurology 68: 828-836 (2007).
21. Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer IL, Jolles J, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol 246: 477-485 (1999).
22. Grundman M, Sencakova D, Jack CR Jr, Petersen RC, Kim HT, Schultz A, et al. Alzheimer's disease cooperative study. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci 19: 23-27 (2002).
23. Rusinek H, De Santi S, Frid D, Tsui WH, Tarshish ChY, Convit A, et al. Regional brain atrophy rate predicts future cognitive decline: 6 - year longitudinal MR Imaging study of normal aging. Radiology 229: 691-696 (2003).
24. Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve DS, Petersen RC, et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130: 1777-1786 (2007).
25. Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer's disease and mild cognitive impairment. Clin Neuropathol 25: 265-271 (2006).
26. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 49: 786-794 (1991).
27. Markesbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 63: 38-46 (2006).
28. Price JL, Morris JC. Tangles and plaques in non-demented ageing and preclinical Alzheimer's disease. Ann Neurol 45: 358-368 (1999).
29. Delis DC, Kramer JH, Kaplan E, Ober BA. CVLT Adult Version. The Psychological Corporation, Harcourt Brace & Company, San Antonio (1987).
30. Reitan RM. Validity of the Trial Making Test as an indicator of organic brain damage. Percept Mot Skills 8: 271-276 (1958).
31. Benton AL, Hamsher K deS. Multilingual Aphasia Examination. AJA Associates, Iowa City (1989).
32. Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Lea Febiger, Philadelphia (1983).
33. Łojek E, Sta-czak J. Ruff Figural Fluency Test. Manual in Polish. PT Psycholog, Warszawa (2004).
34. Bornstein RA, Leason M. Effects of localized lesions on the Verbal Concept Attainment Test. J Clin Exp Neuropsychol 7: 421-429 (1985).
35. Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the Sniffin' Sticks including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3.000 subjects. Eur Arch Oto-rhino-laryngol 264: 237-243 (2006).
36. Scinska A, Wrobel E, Korkosz A, Zatorski P, Sienkiewicz-Jarosz H, Lojkowska W, et al. Depressive symptoms and olfactory function in older adults. J Psychiatry Clin Neurosci 62: 450-456 (2008).
37. Jack CR Jr, Twomey CK, Zinsmeister AR, Sharbrough FW, Petersen RC, Cascino GD. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults. Radiology 172: 549-554 (1989).
38. Lojkowska W, Ryglewicz D, Jedrzejczak T, Minc S, Jakubowska T, Jarosz H, et al. The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia. J Neurol Sci 216: 119-126 (2003).
39. Go--biowski M, Barcikowska M, Pfeffer A. Magnetic resonance imaging- based hippocampal volumetry in patients with dementia of the Alzheimer type. Dement Geriatr Cogn Disord 10: 284-288 (1999).
40. Yavuz BB, Ariogul S, Cankurtaran M, Oguz KK, Halil M, Dagli N, et al. Hippocampal atrophy correlates with the severity of cognitive decline. Int Psychogeriatr 19: 767-777 (2007).
41. Laakso MP, Soininen H, Partanen K, Helkala EL, Hartikainen P, Vainio P, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm Park Dis Dement Sect 9: 73-86 (1995).
42. Ray KM, Wang H, Chu YF, Hasso AN, Su MY. Mild cognitive impairment: apparent diffusion coefficient in regional gray matter and white matter structures. Radiology 241: 197-205 (2006).
43. Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol Psychiatry 43: 60-68 (1998).
44. Jack CR Jr, Petersen RC, Xu YC, Warring SC, O'Brien, Tangalos EG, et al. Medial temporal atrophy on MRI in normal ageing and very mild Alzheimer's disease. Neurology 49: 786-794 (1997).
45. Tapiola T, Pennanen C, Tapiola M, Tervo S, Kivipelto M, Hanninen T, et al. MRI of hippocampus and entorhinal cortex in mild cognitive impairment: a follow up study. Neurobiol Aging 29: 31-38 (2008).
46. Teipei SJ, Prussner JC, Feltraco F, Born C, Rocha-Unold M, Evans A, et al. Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI. J Neurol 253: 794-800 (2006).
47. De Toledo Morrell L, Dickerson B, Sullivan MP, Spanovic C, Wilson R, et al. Hemisphere differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus 2: 136-142 (2000).
48. Bottino CM, Castro CC, Gomes RL, Buchpiguel CA, Marchetti RN, Netto MR. Volumetric MRI measurement can be differentiate Alzheimer's disease, mild cognitive impairment and normal ageing. Int Psychogeriatr 1: 59-70 (2002).
49. Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennet D, et al. Loss and atrophy of Layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 49: 202-213 (2001).
50. Du AT, Schuff N, Kramer JH, Ganzer S, Zhu XP, Jagust WJ, et al. Higher atrophy rate of entorhinal cortex than hippocampus in AD. Neurology 62: 422-427 (2004).
51. Pantel J, Kratz B, Essing M, Schröder J. Parahipocampal volume deficits in subjects with ageing - associated cognitive decline. Am J Psychiatry 160: 379-382 (2003).
52. Mizuno K, Wakai M, Takeda A, Sobue G. Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study. J Neurol Sci 173: 18-24 (2000).